Back/Edgewell Personal Care Sells Feminine Care Business to Essity for Strategic Portfolio Focus
pharma·November 14, 2025·epc

Edgewell Personal Care Sells Feminine Care Business to Essity for Strategic Portfolio Focus

ED
Editorial
Cashu Markets·3 min read
TL;DR
  • Edgewell Personal Care is selling its feminine care business to Essity for $340 million to streamline its portfolio.
  • The divestiture will enhance Edgewell's financial position and focus on core categories for long-term growth.
  • Edgewell anticipates a positive financial impact, boosting adjusted EPS by $0.40 to $0.50 post-sale.

Edgewell Personal Care Divests Feminine Care Business to Essity in Strategic Shift

Edgewell Personal Care Company has entered into a definitive agreement to sell its feminine care business to Essity, a Swedish global health and hygiene company, for $340 million. This sale includes renowned brands such as Playtex®, Stayfree®, Carefree®, and o.b®. As part of Edgewell’s strategic initiative to streamline its portfolio, the transaction is anticipated to close in the first quarter of 2026, pending the necessary regulatory approvals. By divesting this segment, Edgewell aims to enhance its focus on core categories, thereby strengthening its financial position and facilitating investments in long-term growth opportunities.

Rod Little, President and CEO of Edgewell, emphasizes that this move is designed to create a more agile company, ultimately benefiting shareholders and allowing for continued innovation and superior service to customers. The sale also opens up new opportunities for employees, who will transition to Essity. Meanwhile, Essity's CEO, Ulrika Kolsrud, expresses enthusiasm about integrating these well-established brands into their portfolio, aligning with the company’s intent to concentrate on high-yield categories within North America, which is the largest hygiene market globally.

Following the deal's completion, Edgewell plans to classify the feminine care business as discontinued operations. The company anticipates incurring certain stranded overhead costs, which it expects to offset largely through income generated from providing transition support services to Essity. Financially, the impact of the sale is projected to enhance Edgewell's adjusted earnings per share (EPS) by $0.40 to $0.50 and increase adjusted EBITDA by $35 to $45 million. The decision reflects Edgewell's ongoing efforts to refine its market focus while ensuring that its remaining categories can achieve sustainable growth.

In related developments, Essity's acquisition aligns with its strategy to solidify its position in the North American personal care market. With existing brands like Libresse and Bodyform, the addition of Edgewell's feminine care portfolio is expected to bolster Essity's operational capabilities and market share. The transaction also highlights the evolving landscape of the hygiene and personal care industry, where companies are increasingly seeking to optimize their portfolios for improved profitability and market relevance.

As the sale progresses, both companies plan to maintain open communication with stakeholders to ensure a smooth transition and continued focus on consumer needs within the feminine care segment. This strategic divestiture marks a pivotal moment for Edgewell as it concentrates on its foundational categories while providing Essity with the resources to expand its market footprint in a competitive environment.